Analyses of pharmacodynamic (PD) assessments collected during expanded cohorts (EC) of a phase I trial with OSI-930, a multi-targeted oral tyrosine kinase inhibitor (TKI)

Spratlin, J., Arkenau, H. T., George, S., Serkova, N. J., Germuska, Michael ORCID: https://orcid.org/0000-0003-0580-4350, Brock, K., Gedrich, R., Scurr, M., Demetri, G. D. and Camidge, D. R. 2008. Analyses of pharmacodynamic (PD) assessments collected during expanded cohorts (EC) of a phase I trial with OSI-930, a multi-targeted oral tyrosine kinase inhibitor (TKI). EJC Supplements 6 (12) , p. 19. 10.1016/S1359-6349(08)71981-5

Full text not available from this repository.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Psychology
Subjects:	R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Publisher:	Elsevier
ISSN:	1359-6349
Last Modified:	27 Oct 2022 09:22
URI:	https://orca.cardiff.ac.uk/id/eprint/65396

Actions (repository staff only)

Edit Item